We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Computer Prescribing System and Impaired Renal Function (Ordoclic-IR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00784381
Recruitment Status : Completed
First Posted : November 3, 2008
Last Update Posted : November 19, 2012
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
To evaluate the quality of orders for target drugs in old patients with impaired renal function, hospitalized or living in long stay units, and to improve these practices by means of a counselling system coupled to a computer prescribing system

Condition or disease Intervention/treatment Phase
Impaired Renal Function Device: computer-assisted counselling about target drugs Phase 3

  Show Detailed Description

Study Design

Study Type : Observational
Actual Enrollment : 12 participants
Time Perspective: Prospective
Official Title: Impact of a Counselling System Coupled With a Computer Prescribing System to Optimize the Use of the Drugs for Old Subjects Having Renal Function Impairment
Study Start Date : May 2007
Primary Completion Date : December 2008
Study Completion Date : December 2008

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Tests
U.S. FDA Resources

Groups and Cohorts

Group/Cohort Intervention/treatment
1 Device: computer-assisted counselling about target drugs
implementation in experimental units of a software coupled to electronic prescribing system . This software is operating in patients with creatinine clearance below 60 ml/mn. When a target drug is prescribed to such a patient, the software checks if the drug is contraindicated due to impaired renal function, and if not checks if the dose is appropriate relatively to creatinine clearance value
2
These units use the same electronic prescribing system, but had no counselling software
Device: computer-assisted counselling about target drugs
implementation in experimental units of a software coupled to electronic prescribing system . This software is operating in patients with creatinine clearance below 60 ml/mn. When a target drug is prescribed to such a patient, the software checks if the drug is contraindicated due to impaired renal function, and if not checks if the dose is appropriate relatively to creatinine clearance value


Outcome Measures

Primary Outcome Measures :
  1. Comparison of the changes from baseline of proportions [patients with inappropriate target drug prescribing/patients with creatinine clearance<60 ml/mn] between control and intervention groups [ Time Frame: 6 months ]

Secondary Outcome Measures :
  1. Time-related improvement of target drug prescribing in intervention units [ Time Frame: 9 months ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients hospitalized in geriatric units
Criteria

Inclusion Criteria:

  • geriatrics hospital units or nursing homes
  • using the same electronic prescribing system called ORDOCLIC
  • agreeing to participate in the study

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00784381


Locations
France
hopital Charles Foix et Université Paris 6
Ivry-sur-Seine, France, 94 200
Sponsors and Collaborators
Assistance Publique - Hôpitaux de Paris
Investigators
Principal Investigator: Joel BELMIN, Prof Assistance Publique - Hôpitaux de Paris
More Information

Responsible Party: Assistance Publique - Hôpitaux de Paris
ClinicalTrials.gov Identifier: NCT00784381     History of Changes
Other Study ID Numbers: AOM 05118
First Posted: November 3, 2008    Key Record Dates
Last Update Posted: November 19, 2012
Last Verified: October 2008

Keywords provided by Assistance Publique - Hôpitaux de Paris:
Renal failure
Elderly
Drug Therapy Computer-Assisted
Quality of care
Patients With Impaired Renal Function
Inappropriateness of target drug prescribed

Additional relevant MeSH terms:
Renal Insufficiency
Kidney Diseases
Urologic Diseases